APPLICATION
ANDA075667
TYPE
ANDA
ORIGINAL APPROVAL
2000-07-28
LATEST ACTION
2024-01-19
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 5MG BASE · CAPSULE · ORAL
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 1MG BASE · CAPSULE · ORAL
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 10MG BASE · CAPSULE · ORAL
TERAZOSIN HYDROCHLORIDEPrescription
TERAZOSIN HYDROCHLORIDE EQ 2MG BASE · CAPSULE · ORAL
Approval history
2024-01-19Manufacturing (CMC) · Supplement 2 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.